GLP-1 Drugs: What we know, what we don’t, and why everyone’s watching

GLP-1 drugs weren’t supposed to become pop culture icons. Originally, they were developed quietly in labs to help people with type 2 diabetes keep their blood sugar under control. These drugs work by mimicking a natural hormone—glucagon-like peptide-1—that helps the body release insulin when it’s needed and slows down the emptying of the stomach. For years, that was the main goal: better blood sugar management and fewer diabetes complications.

But the story didn’t stop there. Companies like Novo Nordisk and Eli Lilly quickly discovered something that would change the landscape: patients on these drugs were also losing weight—and not just a little. Clinical trials showed average weight losses around 10–15% of body weight. That’s significant, especially when you remember how difficult it is for most people to keep weight off with diet and exercise alone.

Word spread fast. What started as a medical solution turned into something much bigger, thanks in part to social media. Suddenly, brand names like Ozempic and Wegovy were everywhere—trending on TikTok, discussed on podcasts, and mentioned casually at dinner parties. Before-and-after photos flooded feeds. Some people shared stories of finally feeling in control of cravings. Others warned about unpleasant side effects. Demand skyrocketed. Pharmacies struggled to keep up. Some clinics began offering compounded versions, raising safety questions.

Behind the hype, the drugs’ benefits remain clear and well-documented. For people with type 2 diabetes, GLP-1 drugs help bring blood sugar closer to normal levels and can reduce the risk of complications like heart disease. For people using them primarily to lose weight, the results can be life-changing: lower blood pressure, improved cholesterol, and in some cases, even reduced risk of heart attacks and strokes. Many people describe a quieter mind around food—they simply think about eating less, which makes it easier to stick to healthier habits.

Still, for all the excitement, there’s a lot we don’t know. Most studies track people for just a couple of years. What happens when someone uses these drugs for five years? Ten? And what about when they stop? Early evidence suggests that most people regain the weight once the medication is discontinued, often quickly. That suggests GLP-1 drugs might need to be taken long-term, similar to how someone might stay on blood pressure medication.

There are also questions about how these drugs affect mental health. Some users describe emotional blunting or say eating becomes less enjoyable. Scientists are still trying to understand why that happens and how common it really is. Beyond health, there’s also the issue of cost. These drugs aren’t cheap, and insurance coverage is inconsistent—especially for people who want them purely for weight loss rather than diabetes. This raises tough questions about fairness and who gets access to treatment.

Pharmaceutical companies aren’t standing still. They’re running long-term studies and collecting data from wearables and health apps to better track how these drugs perform in real life. Meanwhile, patients are documenting their journeys online—weight changes, side effects, cravings, moods. Doctors and clinics, too, are building databases that track real-world outcomes. Together, this creates an enormous, constantly updating picture of how these drugs are changing lives—for better and sometimes for worse.

The next wave of drugs is already in development. Some combine GLP-1 with other hormones to boost effectiveness and possibly reduce side effects. Early results show even more weight loss and better blood sugar control, raising hopes for what’s to come. But the faster these drugs spread, the more important it becomes to ask hard questions about safety, responsibility, and access.

What makes GLP-1 drugs different isn’t just the science behind them—it’s how they’ve entered daily life. They’ve shifted conversations about obesity and diabetes, turning what used to feel like an intractable problem into something that, at least for some, feels manageable. But it’s crucial to remember they aren’t magic. They work best alongside healthier eating, exercise, and long-term lifestyle changes. And they may need to be taken indefinitely to keep the benefits.

What we know is impressive: meaningful weight loss, better blood sugar control, and possible heart benefits. What we don’t know—long-term safety, psychological impact, and what happens after stopping—still matters deeply. The responsibility for finding those answers doesn’t fall on drug companies alone. Doctors, researchers, and patients all have a role in making sure these drugs are used wisely, safely, and fairly.

What started quietly as a diabetes treatment has become a global phenomenon. The science is strong, but the story isn’t finished. We know a lot, but we don’t know everything. And that’s why so many people are still paying close attention—watching, sharing, and asking what comes next.

Interested in learning more about how digital body measuring can provide greater insights into patient care and the impact prescribed treatments are having? Connect with our business development team today.

Interested in using MeThreeSixty to help track your personal weight loss journey? Download it today and start scanning.